SynthesisFrontiers in neuroscience2024
Textural analysis and artificial intelligence as decision support tools in the diagnosis of multiple sclerosis - a systematic review.
Synthesis in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Magnetic resonance imaging (MRI) is conventionally used for the detection and diagnosis of multiple sclerosis (MS), often complemented by lumbar puncture-a highly invasive method-to validate the diagnosis. Additionally, MRI is periodically repeated to monitor disease progression and treatment efficacy. Recent research has focused on the application of artificial intelligence (AI) and radiomics in medical image processing, diagnosis, and treatment planning. Methods: A review of the current literature was conducted, analyzing the use of AI models and texture analysis for MS lesion segmentation and classification. The study emphasizes common models, including U-Net, Support Vector Machine, Random Forest, and Results: The analysis revealed a fragmented research landscape, with significant variation in model architectures and performance. Evaluation metrics such as Accuracy, Dice score, and Sensitivity are commonly employed, with some models demonstrating robustness across multi-center datasets. However, most studies lack validation in clinical scenarios. Discussion: The absence of consensus on the optimal model for MS lesion segmentation highlights the need for standardized methodologies and clinical validation. Future research should prioritize clinical trials to establish the real-world applicability of AI-driven decision support tools. This review provides a comprehensive overview of contemporary advancements in AI and radiomics for analyzing and monitoring emerging MS lesions in MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.